Management of sarcoidosis.
D000208:Acute Disease; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D062365:Aminobenzoates / Q000627:therapeutic use; D002118:Calcium / Q000097:blood / Q000652:urine; D002648:Child; D002738:Chloroquine / Q000627:therapeutic use; D002908:Chronic Disease; D003937:Diagnosis, Differential; D004417:Dyspnea / Q000188:drug therapy; D005128:Eye Diseases / Q000188:drug therapy; D005260:Female; D006331:Heart Diseases / Q000188:drug therapy; D006801:Humans; D008177:Lupus Vulgaris / Q000188:drug therapy; D009461:Neurologic Manifestations; D010113:Oxyphenbutazone / Q000627:therapeutic use; D011247:Pregnancy; D011248:Pregnancy Complications; D011859:Radiography; D012507:Sarcoidosis / Q000150:complications / Q000175:diagnosis* / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000473:pathology; D012877:Skin Manifestations; D014221:Triamcinolone / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D062365:Aminobenzoates; D014221:Triamcinolone; D002738:Chloroquine; D010113:Oxyphenbutazone; D002118:Calcium